Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth

Go back to Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
(NASDAQ: PGEN) Delayed: 7.10 -0.04 (0.56%)
Previous Close $7.14    52 Week High
Open $7.12    52 Week Low
Day High $7.27    P/E N/A 
Day Low $7.08    EPS
Volume 2,192,988